Home / Alteplase / United States
US ATC B01AD02 · updated 2 Nov 2026
Alteplase shortage in United States
Is there an Alteplase shortage in United States?
Yes. As of 2 Nov 2026, 1 Alteplase product is reported short in United States, the first since 21 May 2026. No return date has been given. Main reason: not stated.
Also short in Canada. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Activase, Injection, 1 KIT in 1 CARTON (50242-085-27) * 100 mL in 1 VIAL, SINGLE-USE * 100 mL in 1 VIAL, SINGLE USE (NDC 50242-085-27) discontinuation | Genentech, Inc | 21 May 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).